Thomas Charles Reilly - Chief Financial Officer at Cara Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CARA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Charles Reilly since 9/17/2023

Holdings reported by Thomas Charles Reilly for Cara Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 37.8K $46.1K $1.22 Mar 3, 2022 Direct
Employee Stock Option (Right to Buy) 40K Feb 25, 2022 Direct Common Stock

Transactions reported by Thomas Charles Reilly for Cara Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.